BioCentury
ARTICLE | Clinical News

Cysteamine bitartrate regulatory update

April 28, 2014 7:00 AM UTC

The European Commission granted Orphan Drug designation to Raptor's RP103 to treat pancreatic cancer. The product is approved as Procysbi in the EU and U.S. to treat nephropathic cystinosis, for which...